Senate Resolution No. designates May 4-10, 2025, as Tardive Dyskinesia Awareness Week to raise awareness about tardive dyskinesia (TD), a condition that can arise from prolonged use of antipsychotic medications, which are often necessary for managing serious mental illnesses. The resolution highlights that TD is characterized by uncontrollable and abnormal movements, and emphasizes that certain populations, including older adults, women, and individuals with specific mental health conditions, are at a higher risk. Alarmingly, around 60% of the estimated 800,000 American adults living with TD remain undiagnosed, which can lead to stigmatization and a decline in overall well-being.

The resolution calls for increased education and awareness regarding TD screening for healthcare providers, patients, and caregivers, in line with the American Psychiatric Association's recommendations for routine screening. It encourages individuals experiencing symptoms of TD to consult their healthcare providers for assessment and potential treatment options, as FDA-approved treatments can significantly improve quality of life. By designating this week, the Senate aims to promote early detection and intervention, ensuring that those affected receive the necessary support and care.